4//SEC Filing
Harness Jane A. 4
Accession 0001123292-17-001399
CIK 0001355250other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 6:23 PM ET
Size
8.8 KB
Accession
0001123292-17-001399
Insider Transaction Report
Form 4
Harness Jane A.
Vice President
Transactions
- Award
Class A Common Stock
2017-09-01+58,394→ 116,788 total - Tax Payment
Class A Common Stock
2017-09-01$0.71/sh−6,056$4,300→ 110,732 total - Award
Employee Stock Option (right to buy)
2017-09-01+172,987→ 172,987 totalExercise: $0.71Exp: 2027-09-01→ Class A Common Stock (172,987 underlying)
Footnotes (3)
- [F1]Represents restricted stock vesting in three equal annual installments beginning on September 1, 2018.
- [F2]Represents shares withheld for payment of tax liability arising as a result of the partial settlement of restriced stock awards that vested.
- [F3]The option vests in three equal annual installments on September 1, 2018, 2019 and 2020.
Documents
Issuer
Innovation Pharmaceuticals Inc.
CIK 0001355250
Entity typeother
Related Parties
1- filerCIK 0001702800
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 6:23 PM ET
- Size
- 8.8 KB